Estimates Revisions GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Delayed
NSE India S.E.
11:59:26 01/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2,768.60 INR | -0.03% |
|
-2.09% | +11.98% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
GlaxoSmithKline Pharmaceuticals Limited(GLAXO)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
GlaxoSmithKline Pharmaceuticals Limited(GLAXO)
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
GlaxoSmithKline Pharmaceuticals Limited(GLAXO)
EBIT
Dividend / Share (DPS)
Data source:
GlaxoSmithKline Pharmaceuticals Limited(GLAXO)
Select your edition
All financial news and data tailored to specific country editions
